Highlights and Quick Summary
- Non-operating Interest Expenses for the quarter ending March 31, 2022 was $60.6 Thousand (a 2566.4% increase compared to previous quarter)
- Year-over-year quarterly Non-operating Interest Expenses increased by 1172.6%
- Annual Non-operating Interest Expenses for 2021 was $4.4 Million (a 27322.24% increase from previous year)
- Annual Non-operating Interest Expenses for 2021 was $16 Thousand (a -99.54% decrease from previous year)
- Annual Non-operating Interest Expenses for 2020 was $3.52 Million (a 661.87% increase from previous year)
- Twelve month Non-operating Interest Expenses ending March 31, 2022 was $1.3 Million (a -44.27% decrease compared to previous quarter)
- Twelve month trailing Non-operating Interest Expenses decreased by -50.97% year-over-year
Trailing Non-operating Interest Expenses for the last four month:
| 31 Mar '22 | 31 Dec '21 | 30 Sep '21 | 30 Jun '21 |
|---|---|---|---|
| $1.3 Million | $2.34 Million | $3.34 Million | $2.66 Million |
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-operating Interest Expenses of Biofrontera AG Sponsored ADR
Most recent Non-operating Interest Expensesof BFAGY including historical data for past 10 years.Interactive Chart of Non-operating Interest Expenses of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Non-operating Interest Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | $0.06 | – |
| 2021 | $0.0 | $1.24 | $0.0 | $1.1 | $4.4 |
| 2020 | – | – | $1.0 | $0.56 | $3.52 |
| 2019 | – | – | $1.21 | $0.46 | $3.04 |
| 2018 | – | – | – | $0.41 | $2.11 |
| 2017 | – | – | $0.44 | $0.19 | $1.28 |
| 2016 | – | – | – | – | $1.34 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic